Dong-A ST challenges ‘Viread’ with ‘Virreal,’ hepatitis B treatment
Dong-A ST will challenge ‘Viread’ by launching ‘Virreal Tab,’ a hepatitis B treatment, on the 1st of October.
Virreal Tab is a product which changed fumarate from tenofovir disoproxil fumarate, the main substance of ‘Viread Tab, ‘a hepatitis B treatment, to orotates, and acquired approval from t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
